Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Association with Quantitative Response to Attention-Deficit/Hyperactivity Disorder Medication of the Previously Identified Neurodevelopmental Network Genes.

Journal of child and adolescent psychopharmacology - 1 Jul 2020

Zhong Yuanxin, Yang Binrang, Su Yi, Qian Ying, Cao Qingjiu, Chang Suhua, Wang Yufeng, Yang Li

Abstract excerpt

Objective: A recent pharmacoimaging study suggested that methylphenidate (MPH) and atomoxetine (ATX) might have common mechanisms for the treatment of attention-deficit/hyperactivity disorder (ADHD). Previous pharmacogenetic studies have by and large only involved genes in neurotransmitter systems, which accounted for very small variances. Therefore, this study aimed to investigate whether the neurodevelopmental...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention Deficit Disorder with Hyperactivity
Share to Attention Deficit Hyperactivity Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System Stimulants

Share to Genome-Wide Association Study

Share to Methylphenidate

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Source

Identifiers

PMID: 32175767
DOI: 10.1089/cap.2018.0164

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Association with Quantitative Response to Attention-Deficit/Hyperactivity Disorder Medication of the Previously Identified Neurodevelopmental Network Genes.PMID 32175767Read ↗

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.Semantic proximity Read ↗

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Meta-analysis of Genome wide Association Studies on Childhood ADHD Symptoms and Diagnosis Reveals 17 Novel Loci and 22 Potential Effector GenesSemantic proximity Read ↗

Update on genetics of attention deficit/hyperactivity disorder: current status 2023.Semantic proximity Read ↗

Genetic risk factors and gene–environment interactions in adult and childhood attention-deficit/hyperactivity disorderSemantic proximity Read ↗

Genetics of attention-deficit/hyperactivity disorder: current findings and future directions.Semantic proximity Read ↗

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Semantic proximity Read ↗

LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.Semantic proximity Read ↗

Shared genetic influences between attention-deficit/hyperactivity disorder (ADHD) traits in children and clinical ADHD.Semantic proximity Read ↗

Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder.Semantic proximity Read ↗

Systematic Review: How the Attention-Deficit/Hyperactivity Disorder Polygenic Risk Score Adds to Our Understanding of ADHD and Associated Traits.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.